NLARx Newsletter Header
NLARx News
November 11, 2009
In This Issue
NLARx News
Conferences and Presentations
In the States
Fraud & Abuse
Health Reform
Prices & Access
Conflicts of Interest
Patents & Generics
Advertising & Marketing
Pharma Watch
PBM Watch
Medicare & Medicaid
Safety & Clinical Trials
Electronic Records
Quick Links
Join Our Mailing List
NLARx News
Report on Nov. 6 NLARx Meeting in Boston More
NLARx Executive Director Warns Federal Trade Policies Threaten State Medicaid Programs More
NLARx Chair Catania and Executive Director Treat Present at Public Health Conference on Evidence Based Prescribing & Conflicts of Interest  More
Conferences and Presentations
Consumers Union Safe Patient Project Live Forum Webcast: November 17, 2009 10am-3:30pm More
Sixth Annual 340B Coalition Winter Conference: San Francisco, Feb 1-3 More
In the States
VERMONT: Testimony Sharply Divided on Free Drug Samples More
WEST VIRGINIA: State Braces for Medicaid Deficit More
IOWA: Iowans Dropoff Unused Prescriptions More
VIRGINIA: State to Close Pharmacy for the Mentally Ill More
NORTH DAKOTA: Pharmacy Law Opponents Begin Ballot Quest More
SOUTH CAROLINA: State Limiting Some Medicaid Patients to One Pharmacy More
NEVADA: State Faults Facility for Depriving 139 Seniors of Their Medications more
Case Spurs Pharmacies' Fears of Lawsuits Over Drug Abuse More
Fraud and Abuse
Omnicare Settles Charges in Kickback Case More
Amgen Sued by 15 States Over Aranesp Kickbacks More
Amgen Is Accused of Illegal Kickbacks More
Abbott Under Kickback Probe Over Depakote Sales More
Report Criticizes Medicare Fraud Investigations More
AZ Pays Millions to Settle Seroquel Cases More
AZ Agrees to Pay $520M in Seroquel Probe More
Pfizer to Pay $75M in Damages Over Prempro More
Forest Labs in Tentative Deal with US Attorneys Over Marketing Probe More
DOJ Investigates Alleged Fraud By Drugmakers; Sanctions On WellCare Lifted More
Shire CEO: Government Probes are Normal More
The "Tootsie Roll" Recipe: Biotech Managers Charged With Fraud More
Pharmaceuticals and Health Reform
New Evidence of Pharma's Sweetheart Deal More
House Bill Would Allow Feds to Negotiate Medicare Drug Prices More
Pfizer, WellPoint Count on Senate to Soften House Health Bill More
With Reform in Senate, Pharma Strikes Back More
Medicaid Drug Discount Out of Health Reform More
Health Bills Aim a Light on Doctors' Conflicts More
Conflicts of Interest Examined Between Doctors and Medical Industry, AARP and Health Reform More
Prices and Access to Health Care
Employees Face Rising Health Care Costs More
Consumers In Search Of Saving Money Should Reconsider Prescription Drug Choices More
When Doctors Create Their Own Evidence-Based Medicine More
Living on Biologics at $32,000 a Month? More
Millions Die Due to High Prices for Malaria Drugs More
Universities Pledge Access to Poor Countries More
Conflicts of Interest
Most Academic Researchers Have Industry Ties More
Should Drugmakers Disclose Free-Sample Handouts? More
At Top Schools, More Than Half the Profs Have Industry Ties More
Undisclosed Conflicts At University Of Wisconsin More
Sunshine Treatment: Payments to Academics More
WSJ Closing Bureau That Pioneered Medical Conflict-of-Interest Reporting More
Drugmakers Place Caps on Speaker Fees: Study More
Patents and Generics
Sen. Sherrod Brown: Biologics Should Not Be Subject To An "Endless Monopoly Period" More
Rep. Anna Eshoo: Setting the Record Straight on Our Health Care Legislation More
Access to US Biosimilars Market Set to Get Tougher More
Generics Firms Close in on Lipitor More
Supremes Turn Away Plavix Patent Challenge More
Patents on Genes Can Be Challenged, Court Rules More
Advertising and Marketing
Pfizer Broke the Law by Promoting Drugs for Unapproved Uses More
What Does IMS Health Do, Anyway? More
So Maybe DTC Ads Aren't Worth It, After All More
Is It Time to Back Off DTC Advertising?  More
Kellogg: Rice Krispies Won't Protect Your Kid From Swine Flu More
A Universal Safety Symbol for Drug Web Sites? More
Justice eyes marketing at J&J, Forest More
PhRMA Pitches Solution to Online Ad Woes More
The Most Persuasive Celebs for Endorsements Are... More
Abbott Labs Probed Over Depakote Marketing More
Marketing Nexium as Superior to Prilosec Was Legal More
How to Market a Drug Off Label More
Pharma Watch
Pfizer, Then and Now: Shareholder Say On Executive Pay More
Which R&D Sites Is Pfizer Closing? More
Where GSK Is Cutting Sales Reps, and Where It's Adding Them More
Recapping 40,000 Job Cuts in Big Pharma More
Merck CEO 'Actively Looking' for Biotech Deals More
PBM Watch
CVS Investigated By FTC Over Business Practices More
CVS Says It Is Subject of FTC Investigation More
CVS Caremark Must Change Pitch to Save Merger More
CVS Caremark Cut To Mkt Perform From Outperform More
Medco CEO: Open To Acquisitions But Growing Very Well Without More
Express Scripts and Greatwater Software Announce Partnership to Provide New Service in Physician Offices More
More Generics, More Frugal Clients for Medco More
Omnicare and Ivax Pay $112 Million Over Kickback Charges More
Antipsychotic Drugs, Elderly Patients and Omnicare's Settlement More
Medicare and Medicaid
It's Re-Evaluation Time for Medicare Part D Beneficiaries More
Enrollment Is Driving Medicaid Costs-But Two Targets Can Yield Savings More
Adverse Selection In The Medicare Prescription Drug Program More
Kaiser Family Fund Releases Medicare Part D 2010 Data Spotlights More
Safety and Clinical Trials
New FDA Program Targets Drug Dosage Errors More
FDA aims to fight avoidable harm from medicines More
Lack of Evidence a Problem for Policymakers, Doctors and Patients More
Awareness: On Drug Labels, Vital Facts May Be Missing More
Bending the Rules of Clinical Trials More
Whytorin? Merck Cholesterol Pills Face Another Test More
Doubling up on flu shots OK, study shows  More
Ongoing FDA Issues aren't stopping Ranbaxy More
Accutane Linked to Inflammatory Bowel Disease More
Antidepressants + Pregnancy = Higher Risks: Study More
Schering-Plough Laxative Lawsuit 'Jumped the Gun' More
Zetia Plus Lipitor? For Now, FDA Won't Consider It More
Electronic Records
Evidence Of An Emerging Digital Divide Among Hospitals That Care For The Poor More
GE Takes a Swing at Health IT Networking Opportunities More